HOME >> BIOLOGY >> NEWS
CRESIB coordinates an international consortium to fight malaria caused by Plasmodium vivax

The CRESIB has today presented the research programme on malaria by Plasmodium vivax, a parasite causing over 70 million yearly cases of malaria in the world. This new programme will be developed in coordination with the leading international centres and researchers on P.vivax. The aim of this study is to contribute to a better understanding of malaria by P. vivax and to support and accelerate the development of new control tools, with a special focus in vaccines. This fact will promote the creation and development of a research line on P. vivax in CRESIB under the direction of Dr. Hernando A. del Portillo, one of the few specialists in molecular biology and vaccine development against this parasite. The number of CRESIB labs will be increased, with an enlargement and restoration of current facilities to meet the needs of the centre.

Malaria is an infectious disease which can be caused by four species of the Plasmodium parasite: P. falciparum, P. vivax, P. malariae and P. ovale. P. falciparum and P. vivax are the most prevalent, the first being more virulent and responsible of most of the severe morbidity and mortality. Nevertheless, during the last years, there has been a growing interest in malaria by P. vivax, which, as well as causing millions of malaria cases every year, it also generates a high social and economic cost for endemic countries. It is estimated that about 2,600 million people live in risk zones for P. vivax: central and south-America, Asia, Middle East and occidental Pacific. Clinical and pathogen presentation of P. vivax is not well understood. Despite the traditional belief that clinical malaria caused by this species of the parasite is mild, there are evidences suggesting that it can cause severe clinical patterns and even death of patients.

The paradox is that even though malaria by P. vivax has large global disease burden, this is a poorly studied disease,
'"/>

Contact: Marc de Semir
mdesemir@clinic.ub.es
34-932-275-700
IDIBAPS - Institut d'Investigacions Biomdiques August Pi i Sunyer
17-Jul-2007


Page: 1 2

Related biology news :

1. NYU biologists identify gene that coordinates two cellular processes
2. American buffalo slaughter fueled by international trade
3. 2 MSU professors spearhead international water project
4. Nature surrenders flowery secrets to international team
5. Fibers are center stage at international conference
6. Creation of an international industrial chair in life cycle assessment
7. The Institute of Ecosystem Studies to host an international conference on ecology and urban design
8. No sign that ethnic groups genes cause diabetes, international research team says
9. Research director to be honored at international congress
10. First international conference on self-healing materials
11. Case Western researcher, international team call for better global warming forecasting

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/14/2019)... ... September 12, 2019 , ... ... solutions for drugs, biologics, gene therapies, and consumer health products, today announced that ... biologics business. Dr. Schaffer has played an integral advisory role on the gene ...
(Date:9/8/2019)... Calif. (PRWEB) , ... September 06, 2019 , ... ... Board of Directors of Nanosens Innovations have each authorized the respective companies to ... a subsidiary of Cardea, with the Nanosens brand representing a series of products ...
(Date:8/27/2019)... ... ... Shoreline Biome , a microbiome research company that develops tools for characterizing ... and Karen Woodward as its VP of Business Development. , These two new ... expand the company’s sales worldwide. , Prior to joining Shoreline Biome, Bill McKenzie was ...
Breaking Biology News(10 mins):
(Date:9/17/2019)... ... September 17, 2019 , ... Tucker, a Labrador retriever, was just a puppy ... was limping and lame on his right hip and elbow. At one year of ... “the worst case the vet had seen.” He was prescribed pain medications, both oral ...
(Date:9/17/2019)... ... September 16, 2019 , ... MyBioGate Global ... Focus @ Biotech Week Boston, a forum organized by MyBioGate, Inc. and CUBIO ... , After a careful process of evaluation, twelve companies out of over 200 ...
(Date:9/9/2019)... ... September 09, 2019 , ... Visikol CEO Dr. Michael Johnson ... focused on how best to characterize 3D cell culture models. The inherent problem of ... too thick and opaque to image through and therefore traditional wide-field or even confocal ...
(Date:8/29/2019)... ... August 29, 2019 , ... ... affecting grapevines, a feat they hope will ultimately help protect the multibillion-dollar grape ... several Rochester Institute of Technology faculty and alumni sequenced the microbiome found within ...
Breaking Biology Technology:
Cached News: